Idiopathic Pulmonary Fibrosis (IPF) research hub
8 indexed studies · 6 currently recruiting
- recruiting
A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications
This study looks at how anti-fibrotic medicines for lung scarring might affect your body shape, specifically your muscle and fat. It uses simple tests like body scanners and muscle scans to see if these medicines cause changes not picked up by just weighing yourself.
United Kingdom - recruiting
PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
This study looks at people with certain types of lung scarring (fibrosis) that are getting worse. Researchers want to better understand why some lung conditions progress and how best to identify this progression early. It involves collecting health information, scans, and blood samples over two years.
United States · Australia · Canada - recruitingPHASE3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
This study looks at a long-term treatment called nerandomilast for people with pulmonary fibrosis. It's for those who've used it in a past study. We'll see how safe and effective it is over time, checking if it helps lung function and slows down the disease.
United States · Argentina · Australia - active not recruitingPHASE3
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
This study is looking into a new medication called BMS-986278 for people with progressive pulmonary fibrosis. It aims to see if the medication is safe and effective in slowing down this lung condition.
United States · Argentina · Australia - recruitingPHASE2
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
This study is for people who were in a previous study with an inhaled medicine called AP01 for lung scarring (pulmonary fibrosis). It’s an extension to see how the medicine works over a longer time, using an inhaler twice a day.
United States · Argentina · Australia - enrolling by invitationPHASE3
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease
This study looks at the long-term effects of an inhaled medicine called treprostinil for people with certain lung scarring conditions like Idiopathic Pulmonary Fibrosis. It follows people who've already been part of similar studies to see how safe and helpful the treatment is over time.
United States · Argentina · Australia - recruitingPHASE3
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
This study looks at an inhaled medicine called treprostinil for people with progressive pulmonary fibrosis. It aims to see if it's safe and effective in slowing down this lung condition over 52 weeks. Half get the medicine, half get a dummy treatment.
United States · Argentina · Australia - active not recruitingPHASE2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
This study is testing a new inhaled medicine (AP01) for people with progressive pulmonary fibrosis. It aims to see if it's safe and effective, compared to a dummy medicine, over one year, alongside usual care.
United States · Argentina · Australia